Bill

Bill > SB379


OR SB379

OR SB379
Relating to an exemption for pharmacy receipts under the corporate activity tax.


summary

Introduced
01/13/2025
In Committee
02/05/2025
Crossed Over
Passed
Dead
06/27/2025

Introduced Session

2025 Legislative Measures

Bill Summary

The statement includes a measure digest written in compliance with applicable readability standards. Digest: The Act makes certain pharmacy drug sale receipts not taxed by the corporate activity tax for all tax years. (Flesch Readability Score: 62.8). Removes the sunset on the exemption for receipts from the sale of prescription drugs by certain pharmacies.

AI Summary

This bill modifies existing tax law provisions related to the corporate activity tax (CAT) for pharmacy drug sales, specifically removing the sunset (expiration) date on an existing tax exemption. The bill amends a previous legislative section to apply the tax exemption for prescription drug sales receipts to all tax years, instead of limiting it to tax years between January 1, 2022, and January 1, 2026. By eliminating the sunset provision, pharmacies will continue to be exempt from paying the corporate activity tax on prescription drug sales receipts beyond the previously established timeframe. The bill appears to be a technical amendment that provides a permanent tax exemption for certain pharmacy drug sales, ensuring that these receipts will not be subject to the corporate activity tax in future years. This change is likely intended to support pharmacies by reducing their tax burden and maintaining a consistent tax treatment for prescription drug sales.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (3)

Last Action

In committee upon adjournment. (on 06/27/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...